ММВБ 2 744 1,1%  Nasdaq 8 124 -0,3%  Биткойн 8 017 -2,0%  USD/RUB 64,1160 0,0% 
РТС 1 347 1,2%  S&P500 2 990 -0,2%  Нефть 59,1 0,3%  EUR/RUB 71,0120 0,0% 
Dow 27 002 -0,1%  FTSE100 7 168 -0,6%  Золото 1 490 -0,2%  EUR/USD 1,1075 0,0% 

Курс акций AstraZeneca [ISIN: GB0009895292]

купить
продать

AstraZeneca PLC - Профиль

AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Акционеры

Название Доля (%)
Capital Research & Management Co. (World Investors)4,16
Investor AB (Investment Company)4,07
BlackRock Investment Management (UK) Ltd.3,41
Wellington Management Co. LLP3,17
The Vanguard Group, Inc.2,85
Legal & General Investment Management Ltd.2,20
Norges Bank Investment Management2,18
BlackRock Fund Advisors1,70
Fidelity Management & Research Co.1,67
Dodge & Cox1,32
BlackRock Advisors (UK) Ltd.1,13
Threadneedle Asset Management Ltd.1,04
SSgA Funds Management, Inc.0,96
BlackRock Advisors LLC0,91
M&G Investment Management Ltd.0,91

Адрес

Cambridge Biomedical Campus, CB2 0AA Cambridge
а/я:
Телефон: 442037495000
Факс: 441223352858
Вэб: http://astrazeneca.com

Менеджмент

Katarina Ageborg
Chief Compliance Officer & EVP-Sustainability
Pascal Soriot PhD, MBA
Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer, MBA
Chief Financial Officer & Executive Director
David Fredrickson
EVP, Global Head-Oncology Business Unit
Menelas N. Pangalos, PhD
EVP-Research & Development Biopharmaceuticals
José Baselga MD, PhD
EVP-Research & Development for Oncology
Ruud Dobber, PhD
Executive VP-Biopharmaceuticals Business
Pam P. Cheng, MBA
Executive VP-Operations & Information Technology
Fiona Cicconi
Executive Vice President-Human Resources
Jeffrey Pott
General Counsel
Rob Skelding
Global Director-Media Relations
Colin Reisner, MD
Head-Clinical Respiratory
Marcus Wallenberg
Independent Non-Executive Director
Geneviéve B. Berger MD, PhD
Independent Non-Executive Director
Thomas Kudsk Larsen
Investor Relations Contact
Leif Valdemar Johansson
Non-Executive Chairman
Philip Arthur John Broadley
Non-Executive Director
Nazneen Rahman, PhD
Non-Executive Director
Sherilyn S. McCoy, MBA
Non-Executive Director
Deborah DiSanzo, MBA
Non-Executive Director
Tony Mok
Non-Executive Director
Adrian Charles Noel Kemp
Secretary
Graham Andrew Chipchase
Senior Independent Non-Executive Director
Edward Bradley
Senior VP & Head-Innovative Medicines Oncology

Добавить или редактировать инструмент